Description

The Side Effects of Drugs Annual was first published in 1977. It has been continually published since then as a yearly update to the voluminous encyclopedia, Meyler's Side Effects of Drugs. Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of adverse drug reactions and interactions. An international team of specialists has contributed to the informative Annual by critically interpreting it and by pointing to whatever is misleading.

Key Features

  • Provides a critical yearly survey of new data and trends
  • Special reviews in this Annual include, among other topics, epidemiology of the use of ecstasy, paracetamol and the risk of asthma, combination vaccines/multiple immunizations, interactions of herbal medicines with warfarin, and tyrosine kinase inhibitors
  • Readership

    Pharmacologists, clinicians, pharmaceutical companies, clinical toxicologists, clinical pharmacologists and medical libraries.

    Table of Contents

    Series Page

    Contributors

    Special reviews

    Cumulative indexes of special reviews, Annuals 11–33

    1. Index of drugs

    2. Index of adverse reactions

    Table of Essays, Annuals 1–33

    Mechanistic and clinical descriptions of adverse drug reactions

    1 EIDOS

    2 DoTS

    Definitive (between-the-eyes) adverse drug reactions

    How to use this book

    The scope of the Side Effects of Drugs Annuals

    Period covered

    Selection of material

    Classification of drugs

    Names of drugs and chemicals

    System of tagging references

    Indexes

    Abbreviations

    Side effects of drugs essay

    An agenda for research into adverse drug reactions

    Systematic reviews

    Teleoanalysis

    Conclusions

    1. Central nervous system stimulants and drugs that suppress appetite

    Amphetamines [SED-15, 180; SEDA-31, 1; SEDA-32, 1; SEDA-33, 1]

    Methylxanthines

    Drugs that suppress appetite [SEDA-30, 7; SEDA-31, 9; SEDA-32, 16; SEDA-33, 13]

    Drugs used in Alzheimer’s disease [SEDA-31, 10; SEDA-32, 19; SEDA-33, 15]

    References

    2. Antidepressant drugs

    General

    Selective serotonin re-uptake inhibitors (SSRIs) [SED-15, 3109; SEDA-31, 18; SEDA-32, 33; SEDA-33, 26]

    Serotonin and noradrenaline re-uptake inhibitors (SNRIs)

    Tricyclic antidepressants

    Other antidepressants

    References

    3. Lithium

    References

    4. Drugs of abuse

    Cannabinoids [SED-15, 614; SEDA-31, 33; SEDA-32, 55; SEDA-33, 55]

    Opioid analgesics

    References

    5. Hypnosedatives and anxiolytics

    Azaspirones [SEDA-32, 75; SEDA-33, 71]

    Benzodiazepines [SED-15, 429; SEDA-31, 57; SEDA-32, 75; SEDA-33, 71]

    Benzodiazepine-like drugs

    Benzodiazepine antagonists

    Other hypnosedatives

    References

    6. Anti

    Details

    No. of pages:
    904
    Language:
    English
    Copyright:
    © 2012
    Published:
    Imprint:
    Elsevier
    Print ISBN:
    9780444594990
    Electronic ISBN:
    9780444595034